Discover 186 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 186
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Boston MA, New Haven CT, New York NY, Commack NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Active & Responsive
American Lung Association (ALA) Lung Health Cohort
for
Lung Diseases
Location: Hawthorne NY, New York NY, Colchester VT,
Sponsor: Johns Hopkins University
Sex: All
Age: 25 - 35
Code: NCT04543461
Recruiting
Active & Responsive
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
for
COPD
Location: Boston MA, Burlington MA, Burlington VT, Montreal,
Sponsor: Temple University
Sex: All
Age: 30+
Code: NCT05204888
Recruiting
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: Burlington VT, Hershey PA, Charlottesville VA,
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Active & Responsive
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)